Patient Navigation

Overview:

Epharmix helps self-insured employers and health systems in value-based contracts monitor and communicate with their most challenging patients.

Company description:

Epharmix helps self-insured employers and health systems in value-based contracts monitor and communicate with their most challenging patients.

We use an accessible and engaging system of automated texts and phone calls to collect disease-specific data, and provide a patient's health status in real-time. Our questions are clinically validated by medical experts to ensure that they yield the most impactful patient data.

By automatically triaging those experiencing poor health, we make it easy for care teams to rapidly respond to the right patients. We help care teams spend more time caring for patients, less time collecting data. Our 23 disease-specific tools align with 42 quality metrics or national improvement initiatives, enabling revenue generation and cost savings, in addition to greater staff efficiency.

Jason Roche

Growth Engineer

314-272-2586

jason@epharmix.com

Healthcare Leaders in value-based care arrangements: Hospital executives, health plan executives, HR/benefit/wellness executives, investors connected to healthcare systems and plans (investment arms)

Company name: Epharmix

Date founded: May 2015

Contact:

Jason Roche, Growth Engineer

314-272-2586

jason@epharmix.com

Funding to date: $2 million

Financing sought: N/A

Current investors:

Nobel laureate/Biogen Founder - Dr. Wally Gilbert, XPRIZE founder - Dr. Peter Diamandis, HealthX Ventures, BOLD Capital Partners, 1517 Fund, iSelectFund

Website URL: www.epharmix.com

Facebook: @epharmix

Twitter: @Epharmix

LinkedIn: company/epharmix/

Pitch URL: N/A